NovoCure Ltd — Director's Dealing 2019

Sep 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-08-30

Reporting Person: PHILLIPS CHARLES G III (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-30	Ordinary Shares	M	22000	$6.72	Acquired	31504	Direct
2019-08-30	Ordinary Shares	S	8692	$90.628	Disposed	22812	Direct
2019-08-30	Ordinary Shares	S	12908	$91.458	Disposed	9904	Direct
2019-08-30	Ordinary Shares	S	400	$92.098	Disposed	9504	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-30	Options to Buy Ordinary Shares	$6.72	M	22000	Disposed	2022-09-28	Ordinary Shares (22000)	Direct

Footnotes

F1: On August 30, 2019, Mr. Phillips sold 8,692 shares in multiple trades at prices ranging from $89.92 to $90.91. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: On August 30, 2019, Mr. Phillips sold 12,908 shares in multiple trades at prices ranging from $90.93 to $91.92. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On August 30, 2019, Mr. Phillips sold 400 shares in multiple trades at prices ranging from $91.95 to $92.27. The price reported above reflects the weighted average sale price. Mr. Phillips hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: Fully vested as of the date hereof.